Recently, several hedge funds have increased their investments in Health Catalyst. Nisa Investment Advisors raised its stake by 461%, owning now 6,367 shares worth $41,000 after adding 5,232 shares. Perfromance Wealth Partners and EntryPoint Capital each purchased shares valued at approximately $64,000 and $98,000, respectively. Virtus Investment Advisers acquired shares worth about $115,000. Additionally, The Manufacturers Life Insurance Company increased its holdings by 10.3%, owning now 23,162 shares valued at $148,000. Institutional investors hold 85% of the stock.
Health Catalyst Stock Performance
As of Wednesday, NASDAQ:HCAT opened at $7.83, with a market cap of $462.24 million, a P/E ratio of -4.23, and a beta of 1.32. Its 50-day and 200-day moving averages are $7.43 and $6.88, respectively, with a 1-year low of $5.42 and a high of $11.41.
Health Catalyst reported its quarterly earnings on August 7th, showing $0.12 earnings per share, better than the expected $0.08. Revenue was $75.90 million, slightly above analyst estimates. The company had a negative profit margin of 28.87% and a negative return on equity of 9.38%, but revenues increased by 3.7% year-over-year.
Wall Street Opinions
Analysts have updated their ratings on Health Catalyst shares: Evercore ISI raised their target from $8 to $10, while JPMorgan Chase increased theirs from $10 to $13. Conversely, Stephens lowered their target from $8 to $7. Cantor Fitzgerald maintained an overweight rating with a $16 target, and Piper Sandler cut their target from $14 to $11. The average rating is “Moderate Buy” with a target price of $11.58.
Insider Activity
COO Daniel Lesueur sold 8,137 shares at $7.58, totaling $61,678. Following this, he retains 140,108 shares worth about $1.06 million. Another insider, Kevin Lee Freeman, sold 7,500 shares at $7.22 for $54,150, keeping 255,881 shares valued at roughly $1.85 million. Overall, insiders sold 35,362 shares valued at $256,009 in the last quarter, and corporate insiders own 2.7% of the stock.
About Health Catalyst
Health Catalyst, Inc. offers data and analytics technology to healthcare organizations in the U.S. It operates in two segments: Technology and Professional Services, providing a comprehensive data platform and analytical software for various healthcare applications.
See Also
- Five stocks we like better than Health Catalyst
- How to Calculate ROI
- NVIDIA’s AI Dominance
- Trillion-Dollar Market Cap Significance
- Stocks Using Buybacks for Gains
- Where to Find Earnings Call Transcripts
- PepsiCo Entry Opportunity
Want to see more on HCAT? Visit HoldingsChannel.com for the latest filings and trades.
Receive Daily News & Ratings for Health Catalyst
`
